FLAM:CA:TSX-Franklin FTSE U.S. Index ETF (CAD)

ETF | US Equity |

Last Closing

CAD 21.55

Change

+0.60 (+2.86)%

Market Cap

CAD 0.36B

Volume

4.80K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-08 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
ZSP:CA BMO S&P 500

+0.34 (+0.44%)

CAD 10.81B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.49 (+0.90%)

CAD 9.71B
VFV:CA Vanguard S&P 500 Index ETF

+0.91 (+0.73%)

CAD 8.89B
VUN:CA Vanguard US Total Market

+0.78 (+0.82%)

CAD 7.76B
XUS:CA iShares Core S&P 500 Index ETF

+0.65 (+0.74%)

CAD 5.73B
HXS:CA Horizons S&P 500 Index ETF

+0.50 (+0.69%)

CAD 2.95B
QUU:CA Mackenzie US Large Cap Equity ..

+0.78 (+0.38%)

CAD 2.89B
XUU:CA iShares Core S&P US Total Mark..

+0.38 (+0.73%)

CAD 2.68B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.47 (+0.34%)

CAD 2.66B
VSP:CA Vanguard S&P 500 CAD hedged

+0.70 (+0.83%)

CAD 2.45B

ETFs Containing FLAM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.22% 71% C- 76% C+
Dividend Return 0.34% 35% F 38% F
Total Return -7.88% 72% C 77% C+
Trailing 12 Months  
Capital Gain 0.37% 75% C 82% B
Dividend Return 0.31% 12% F 6% D-
Total Return 0.68% 76% C+ 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.23% N/A N/A N/A F
Dividend Return 0.25% N/A N/A N/A F
Total Return 0.02% N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 3.54% N/A N/A N/A F
Risk Adjusted Return 6.96% N/A N/A N/A F
Market Capitalization 0.36B 75% C 65% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.